Drug can spur liver regeneration in Alagille syndrome


Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the liver, could be reversed with a single drug. The study, published in the Proceedings of the National Academy of Sciences, has the potential to transform treatment for this rare disease and may also have implications for more common diseases.

Amazon announces plans to lay off over 18,000 employees

Previous article

Seroprevalence study demonstrates vaccination could boost impaired humoral immunity against Omicron BQ.1.1 subvariant

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations